Anopheles mosquitoes are vectors of malaria, a potentially fatal blood disease affecting half a billion humans worldwide. These blood-feeding insects include in their antihemostatic arsenal a potent thrombin inhibitor, the flexible and cysteine-less anophelin.
M
alaria is a life-threatening human disease caused by Plasmodium spp. parasites that infect liver and red blood cells, and it is transmitted exclusively through the bites of Anopheles mosquitoes. A. gambiae is the primary vector of malaria in subSaharan Africa, whereas A. stephensi is the main urban vector of the disease in India (1) . Furthermore, A. darlingi and A. funestus are important vectors in Central and South America and Africa during the dry season, respectively (2, 3) . Finally, A. albimanus is the principal malaria vector in most Caribbean countries. Despite important vector control and prophylactic measures, about 225 million cases of malaria and ∼800,000 deaths were reported in 2009, accounting for ∼2% of worldwide deaths and 20% of all childhood deaths in Africa (4) .
Like other hematophagous animals, Anopheles mosquitoes rely on potent inhibitors of the host hemostatic and inflammatory responses for blood ingestion, storage, and digestion. Specific inhibitors of blood coagulation factors and particularly, the final peptidase in the cascade thrombin seem to be critical in this regard. The only mosquito-derived thrombin inhibitor described to date is anophelin (family I77 in the MEROPS classification; http://merops.sanger.ac.uk) (5) , first isolated from A. albimanus salivary gland extracts (6, 7) . Anophelin homologs (less than 50% sequence identity) were identified in A. gambiae (8) , A. stephensi (1), A. darlingi (2) , and A. funestus (3), but with the recent exception of one of the A. gambiae variants (9), they remain uncharacterized ( Fig. 1 shows a sequence alignment of family I77 inhibitors). Interestingly, the anophelin gene is expressed in mosquito salivary glands in response to Plasmodium sporozoite invasion, suggesting a role in parasite infection (10) . Moreover, recent RNAi silencing studies have shown that anophelin depletion in adult A. gambiae mosquitoes results in increased probing time and decreased blood capacity (11) .
A. albimanus anophelin is a potent, tight-binding inhibitor of α-thrombin, the final proteinase of the blood-clotting cascade (7) . Thrombin is an atypical (chymo)trypsin-like enzyme, with stringent specificity arising from its narrow active site cleft and secondary positively charged recognition surfaces (exosites) (12) . Exosites are not only essential for substrate and cofactor binding (13) (14) (15) (16) (17) (18) but also, are targeted by many natural anticoagulants (19) (20) (21) (22) (23) (24) (25) . Thorough kinetic analyses revealed that anophelin is a dual inhibitor that binds both the exosite I and the active site of the target proteinase (6, 7) . Accordingly, anophelin not only blocks physiological thrombin activities, such as fibrinogen clotting and platelet activation, but also abolishes esterolytic activity on small chromogenic substrates.
Here, we report the unique molecular mechanism of thrombin inhibition by anophelin. In contrast to previously characterized natural bivalent inhibitors that contact one of the exosites through their C-terminal regions, anophelin displays an unexpected reversebinding mode to thrombin. This hitherto unobserved binding mechanism explains not only the remarkable affinity and specificity of anophelin but also, its resistance to proteolysis by thrombin, despite lacking disulfide bridges. The key residues for anticoagulant activity have been identified and are highly conserved across similar proteins of Anopheles mosquitoes. The structural and functional data now obtained unravel the essential role of this protein in mosquito blood feeding and open new perspectives to the rational design of improved anticoagulants.
(cE5) from A. gambiae behaves as a specific thrombin inhibitor in vitro (9) . Strictly conserved regions are limited to the N-terminal 1 A-P-Q- 4 Y tetrapeptide, the hirudin-like motif with the consensus sequence 7 15 (D/E), and the downstream 50 D-P-G- 53 R stretch ( Fig. 1 shows a sequence alignment; numbers refer to mature anophelin Aa ). In line with their lack of cysteines and the preponderance of polar residues, anophelins are predicted to be intrinsically disordered in solution (Fig. S1A) . Indeed, the circular dichroism (CD) spectrum of anophelin Aa is typical of random coils, and its deconvolution with different methods suggests a mostly disordered polypeptide (Fig. S1B) .
G-(D/E)-X-P-X-Y-D-E-
Despite the considerable divergence of the anophelin genes, functionally important regions seem to have been preserved, because the five recombinant anophelins retained anticoagulant activity in vitro, prolonging 5-to 13-fold the time necessary for thrombin-catalyzed clotting of blood plasma [thrombin time (TT)] (Table 1) . Furthermore, all anophelins behaved as tight-binding inhibitors of α-thrombin, with K i values between 3.5 and 66 pM (Table 2) , and significantly increased the thermal stability of α-thrombin on complex formation ( Fig. 2A and Table S1 ). In addition, all five homologs were able to inhibit the exosite Idisrupted γ-thrombin (26) at high molar excess (Fig. S2 ).
Arg53 Is Essential for Anophelin Inhibitory Activity. Kinetic studies have suggested anophelin Aa to be a bivalent inhibitor interacting with both the active center and the exosite I of thrombin (7) . Comparison with the amino acid sequence of ideal thrombin substrates hinted that the A D50-A R54 tetrapeptide could fit in an antiparallel, substrate-like manner into the proteinase active site cleft;
A R53 and A R54 are likely candidate P 1 residues for occupying the acidic S 1 pocket of thrombin (27, 28) . [Substrate/inhibitor residues are denoted P n , ..., P 1 , P 1 ′, ..., P m ′, from N-to C-terminal end, where P 1 -P 1 ′ is the scissile peptide bond; the corresponding proteinase subsites that accommodate these residues are termed S n , ..., S 1 , S 1 ′, ..., S m ′ according to the nomenclature in the work by Schechter and Berger (29) .] The sequence is conserved in all known anophelins, except for the A. gambiae homolog, which has an asparagine at position 54 ( Fig.  1) . To verify the putative functional role of these basic residues in thrombin binding and inhibition, several mutants of anophelin Aa were generated and characterized. Mutants R54A, R54N, and R54E prolonged TT to a roughly similar extent as WT anophelin Aa (Table 1) . A similar behavior was observed for R53K, whereas the TTs obtained for R53Q and R53H were about one-half the TTs of the WT protein. Remarkably, mutant R53A was unable to prolong TT at low concentrations and only marginally increased TT (1.8-fold) at concentrations as high as 5 μM.
Anophelin mutants R54A, R54N, and R53K retained the tightbinding inhibition mode of the WT inhibitor, although with 14-, 32-, and 80-fold higher K i values than anophelin Aa , respectively (Table 2) . In striking contrast, the reversal-of-charge mutant R54E and variants in which R53 is replaced by polar residues (R53Q and R53H) were rapid, reversible competitive inhibitors ), and A. funestus (3) and the New World species A. albimanus (6, 7) and A. darlingi (2) (vectors of malaria in sub-Saharan Africa, India, Africa, and Central and South America, respectively) were aligned with ClustalW (64) . Also included is the sequence of TTI (G. morsitans morsitans; MEROPS family I76) (47) . Strictly conserved residues are highlighted in green, whereas other conservative replacements are shaded red. The numbering for mature anophelin Aa is given above the alignment, and the numbering for mature TTI is given above the respective sequence. The figure was prepared with Aline (65). of α-thrombin, with several orders of magnitude higher K i values. More dramatically, R53A failed to inhibit the procoagulant proteinase (Table 2 ). These anophelin mutants also inhibited γ-thrombin with similar relative efficiencies (Fig. S2) .
Surface plasmon resonance (SPR) analysis on immobilized thrombin revealed the formation of a very stable complex with anophelin Aa (K D = 3.65 nM), whereas mutants were one (R54A, R54N, and R53K) or two (R54E, R53Q, and R53H) orders of magnitude less potent binders (Fig. 2B, Table 3 , and Fig. S3 ). Finally, in good agreement with the inhibition studies, no appreciable binding of mutant R53A to the thrombin-coated chip surface was observed (Table 3 and Fig. S3 ). Taken together, these findings suggested a key role for anophelin residue R53 in thrombin binding and inhibition, likely by occupying the S 1 specificity pocket. Although with a milder impact, differences in the kinetic behavior indicated that the positive charge of A R54 contributes to anophelin's strong interaction with thrombin.
Anophelin Displays a Unique Mode of Thrombin Inhibition. To understand the molecular details of thrombin recognition and inhibition by anophelins, the equimolar human α-thrombin·anophelin Aa complex was crystallized, and its structure was determined Electron density maps were readily interpretable for mature anophelin residues A E32 to A P61 (Fig. 3A) , but no significant density was detectable for the remaining N-terminal residues A A1 to A D31. However, the presence of the full-length inhibitor was detected by MS analysis of thrombin·anophelin crystals. Because the N-terminal region of anophelin is facing a solvent-filled channel, it is probably flexibly disordered. This N-terminal segment was similarly disordered in a second crystal form of the anophelin·thrombin complex solved at 3.2-Å resolution (space group H32; rmsd of 0.25 Å for 263 aligned Cα atoms) (Table 4 ) and also in this case, not constrained by crystal packing. Table 3 . Kinetic parameters of anophelin binding to immobilized α-thrombin measured by surface plasmon resonance The most striking result of the structural analysis is that the cysteine-less inhibitor anophelin displays an unexpected mode of binding to thrombin, which is unique for a natural serine proteinase inhibitor. In the two independent crystal structures of the anophelin·thrombin complex, the inhibitor adopts a mostly extended conformation and binds to the proteinase in a reverse orientation (i.e., opposite to substrates) (Fig. S4) . Anophelin interacts with both the active site region (through its C terminus) and the exosite I of the enzyme, establishing the specific contacts briefly described below ( , which accepts hydrogen bonds from the side chains of the catalytic residues T S195 and T H57 (NE2) and the main-chain nitrogen of T G193 (Fig. 3C ). These interactions result in disruption of the critical hydrogen bond between the side chains of T S195 and T H57 (NE2 displaced by 0.74 Å and OG displaced by 1.36 Å on 180°rotation in relation to free thrombin) (30) , with the concomitant disturbance of the characteristic serine proteinase catalytic triad chargerelay system. Accordingly, mutation of this residue to alanine essentially abolished binding to immobilized thrombin (Table 3 and Fig. S3 ) and stabilization as measured by differential scanning fluorimetry (DSF) ( Fig. 2A and Table S1 ). Furthermore, the A D50A mutant did not display significant anticoagulant activity or inhibited γ-thrombin (Tables 1 and 2 and Fig. S2 ). Even the conservative replacements of A D50 by glutamate or asparagine led to a dramatic decrease in inhibition efficiency both in terms of TT prolongation and inhibition kinetics (Tables 1, 2, and 3).
As suggested by mutational studies (see above), the experimental complex structure revealed that thrombin's S 1 pocket is occupied by A R53. However, the reverse-binding mode of anophelin imposes significant differences in the interactions of this residue with the proteinase compared with substrates/substratelike inhibitors (Fig. S5A) . The NH1 atom of the A R53 guanidinium group donates hydrogen bonds to T D189 OD2 and the carbonyl oxygen of T G219, whereas the NH2 nitrogen engages in a water-mediated hydrogen bond with T F227 O (Fig. 3C) . Furthermore, the A R53 carbonyl oxygen is hydrogen-bonded to the main-chain nitrogen of T G219. There is also a unique watermediated interaction between A R53 NE and the catalytic T S195 OG. The extent and quality of these interactions fully corroborate the results of the mutagenesis studies described above.
The S 2 hydrophobic pocket of thrombin is partially occupied by A P51, which slots between T H57 and T W60D, and by A G52, which establishes Van der Waals contacts with T L99 and T W215. The position of this strictly conserved glycine, which is further stabilized by hydrogen bonds between its main-chain nitrogen atom and the carboxylate of A D50 and between its carboxyl oxygen and the main-chain N of T G216, forces A P51 toward the 60-loop (Fig. S5A ). An additional interaction that exploits thrombin's characteristic residues is made by the side chain of the gate-keeping T E192, which flips to accept two hydrogen bonds from Aa make a sharp turn to leave the active site cleft of the proteinase. In this manner, the C-terminal region of the inhibitor runs parallel to and shields from bulk solvent the side chain of A R54, and in addition, it engages in several mostly polar interactions with thrombin. The side chains of A E57 and A K60 form salt bridges to the oppositely charged T K224 and T E146, respectively, whereas the guanidinium group of T R221A hydrogen bonds to the carbonyl oxygen of A E57. However, these solvent-exposed polar contacts seem to only marginally contribute to complex stability, because these residues are not conserved in anophelins from Old World mosquitoes.
C-Terminal Segment of Anophelin Is Sufficient for Tight Thrombin
Inhibition. In the two independent crystal structures of the human α-thrombin·anophelin complex, only the C-terminal portion of the inhibitor, comprising residues A E32 to A P61, was fully defined by electron density. To further verify that this segment was sufficient for thrombin inhibition, the corresponding synthetic peptide (anophelin ) was thoroughly characterized. The anticoagulant and antiamidolytic activities of anophelin were only three-and ninefold lower than the activites of full-length anophelin Aa (Tables 1 and 2 ). The C-terminal inhibitor fragment also bound immobilized α-thrombin with an affinity comparable with the affinity of the full-length form (Fig. 2B and Table 3) , and it had similar effects on proteinase stabilization ( Fig. 2A and Table S1 ).
However, the 31-residue-long N-terminal segment (anophelin ) neither prolonged TT nor inhibited α-or γ-thrombin in vitro (Tables 1 and 2 and Fig. S2 ). Additionally, no interaction of anophelin with α-thrombin was detectable either by DSF assays or SPR analyses ( Fig. 2A, Table 3 , Fig. S3 , and Table S1 ).
Discussion
We have performed a thorough structural and functional analysis of anophelin, a unique anticoagulant from the malaria vector, disclosing an unprecedented molecular mechanism of thrombin inhibition. Studies of the salivary gland transcriptomes of hematophagous animals have revealed that anophelins are exclusively found in Anopheles mosquitoes (1, 2, 33, 34), being absent from the related culicine species, from which they diverged ∼150 Mya (35) . Despite significant sequence divergence between New and Old World species, consistent with the evolutionary separation of the two anopheline branches ∼95 Mya (35), thrombininhibiting activity is retained in anophelin homologs from A. albimanus and A. gambiae (6, 7, 9) . Here, we show that all known family I77 members are effective thrombin-targeting anticoagulants, and we identify the critical residues responsible for the inhibitory activity of anophelins.
Mechanism of Thrombin Targeting by I77 Family Inhibitors. The Cterminal moiety of anophelin establishes a multitude of interactions with the exosite I and the active site of thrombin (Fig. 3A and Fig. S5C) . In contrast to a previous suggestion (9) , the Nterminal hirudin-like motif of anophelin (residues A G7 to A D15 in anophelin Aa ) is not involved in exosite I binding. Instead, this important recognition surface of thrombin is occupied by the acidic A E32-A F45 segment. Similar to other thrombin complexes with substrates, cofactors, and inhibitors (13, 14, (20) (21) (22) (23) and despite complementary electrostatic surface potentials, nonpolar interactions dominate at this interface.
Pivotal to the inhibition mechanism of I77 family members is the unexpected reverse-binding mode to thrombin (Figs. 3A and  4) . Curiously, this binding mechanism is distantly reminiscent of the interaction of X-linked inhibitor of apoptosis with the apoptotic caspases 3 and 7 and the contact between the pro-and catalytic domains of papain-like cysteine proteinases, such as cathepsins B and L (36) (37) (38) . In contrast to the intrinsically disordered anophelins, the extensive contacts between the folded scaffold of X-linked inhibitor of apoptosis and the target proteinases are essential for placing an 8-residue-long segment across the active site of the enzymes, where it establishes a limited number of interactions. Contrary to anophelin, there are no interactions with the catalytic residues, the primed subsites, or even the S 1 and S 2 specificity subsites. In the case of procathepsins, the C-terminal prodomain residues pass across the substrate-binding cleft in a reverse orientation (39, 40) . However, also in this case, binding is dependent on the presentation of these residues by a highly structured moiety, and even limited N-terminal truncation of the prodomain results in a dramatic decrease of inhibitory potency (38) . Anophelin displays a considerably more extensive interaction with the active site cleft of the target proteinase. The most important contribution to the binding energy results from the insertion of the A D50-A R54 segment into the active site cleft of the enzyme, with A R53 occupying thrombin's acidic S 1 specificity pocket. Indeed, singlepoint mutations to alanine convert a tight binding into a poor competitive inhibitor (D50A) or abolish inhibitory activity altogether (R53A) ( Table 2 ). In particular, the multiple interactions established by the A D50 carboxylate with active site residues T H57 and T S195 significantly account to the binding efficiency as indicated by the D50A mutant (ΔΔG°W T-D50A ∼ −9,600 cal·mol ) does not interact with thrombin in the two independent experimental structures reported here, although there is no impairment arising from the crystal packing. In addition, deletion of this segment only marginally reduced anophelin's inhibitory potency in vitro and had essentially no effect in binding to immobilized thrombin. Finally, the isolated N-terminal peptide showed no effect on TT, did not impair thrombin activity against chromogenic substrates, and did not bind to the immobilized proteinase. Altogether, these findings exclude a functional role of anophelin's N-terminal moiety in its antithrombin activity. Several not mutually exclusive explanations can be put forward to explain the striking conservation of this region across I77 family members. In vivo, under high flow conditions, this negatively charged segment might help direct the inhibitor to active thrombin. Alternatively, in thrombin-bound anophelin, this exposed polypeptide might interact with other hitherto unidentified element(s) of the hemostatic system.
Role of Flexibility in Thrombin·Anophelin Complex Formation. As indicated by the CD analysis, anophelin is essentially disordered in solution, and it adopts a definite 3D structure only in complex with the target proteinase (Fig. S1) , similar to what was previously observed for IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae and the cysteine proteinase-targeting calpastatin (41) (42) (43) . However, recent evidence indicates that thrombin itself is more flexible than previously thought and in particular, that exosite I is in dynamic equilibrium in the free proteinase (44) . These findings indicate that formation of a stable complex between thrombin and anophelin deviates significantly from the classical lock-and-key model, and it involves simultaneous stabilization of their 3D structures. Complex formation, in turn, can only occur because the extent and quality of interactions between the two moieties revealed in the current crystal structures exceed the entropy loss caused by reduced degrees of freedom of both thrombin and anophelin. This feature needs to be considered for the design of novel antithrombotics, and it is likely also relevant for other members of the family of trypsin-like serine proteinases.
Comparison with Other Thrombin Inhibitors. Although I77 inhibitors display an original mechanism of serine proteinase inhibition, several structural aspects of the interaction are reminiscent of those aspects previously observed in other thrombin inhibitors. Despite the reverse direction of the respective polypeptide chains, some relevant anophelin interactions resemble those interactions established by the canonical I14 family inhibitor, hirudin, with the regulatory exosite I (19, 32, 45) . In particular, residue A E43 is topologically equivalent to H E57 in hirudin, also establishing a direct polar interaction with the proteinase (Fig. S5C) . In addition, the phenolic side chain of (20, 23) , and I14 family members (19, 24, 32, 45) . Notably, the interaction observed between the S 1 -occupying arginine residue NH1 atom and both T D189 OD2 and T G219 O is preserved in boophilin (23) and hemadin (24) (Fig. S5 A  and B ).
Anophelin as a Model for Other Cysteine-Less Thrombin Inhibitors. It is noteworthy that several thrombin inhibitors isolated from hematophagous animals share with anophelin important features, such as the preponderance of acidic residues and a complete lack of stabilizing disulfide linkages, but they are, nevertheless, not cleaved by the target proteinase. This is, for instance, the case of a potent inhibitor isolated from the tsetse fly, Glossina morsitans morsitans (46, 47) . Inspection of the amino acid sequence of the tsetse inhibitor (TTI; family I76 in the MEROPS database) reveals that the C-terminal end, TTI P28-TTI L32, is closely related to the active site-targeting region of anophelin (numbers for mature TTI) (47) (Fig. 1) , and therefore, it could bind thrombin essentially as revealed in the current structures. Loss of favorable electrostatic interactions with the S 1 pocket because of the replacement of residue A R53 by TTI I30 might be compensated by more extensive contacts with exosite I. In this regard, it is noteworthy that recombinant and synthetic TTIs were much less potent thrombin inhibitors than the natural product (47) (K i values of 150 nM and 584 fM, respectively). This discrepancy has been attributed to a nonidentified posttranslational modification of natural TTI. Sulfation of tyrosine residues at positions 9 and 12 of mature TTI, as predicted by Sulfinator (48), seems to be the likely modification responsible for enhanced affinity of the natural TTI to the procoagulant proteinase. The positive effect of tyrosine sulfation on hirudin binding to thrombin has been wellestablished (45) .
Implications for the Design of Antithrombotics. To date, hirudin is the only natural proteinaceous thrombin inhibitor approved for clinical use. Because of its relatively large size and narrow therapeutic window, considerable efforts have been made to simplify hirudin's scaffold. Briefly, two major paths have been followed, both of which graft the exosite I-binding C-terminal tail of hirudin to distinct active site-targeting moieties (45) . In these hirudomimetics, either reverse binding to the active site is preserved at the expense of a long connecting linker or a substrate-like binding moiety is used, requiring nonpeptidic linkages to the shorter linker to circumvent degradation by thrombin. The molecular mechanism of anophelin, here reported, provides an elegant way to bridge exosite I and parallel active site-binding moieties with the shortest linker described to date, yielding highly specific and potent inhibition, while assuring resistance to proteolysis by thrombin.
Methods
Anophelin Production. A synthetic gene coding for mature A. albimanus anophelin (anophelin Aa ) was generated by PCR-based gene assembly (49) and cloned into pTYB11 (New England BioLabs) in fusion with an N-terminal intein tag. Expression constructs of anophelin Aa point mutants and the truncated anophelin form were generated by site-directed mutagenesis.
Similar constructs coding for anophelin homologs were synthesized at GenScript. Escherichia coli ER2566 cells (New England BioLabs) transformed with pTYB11-anophelin plasmids were grown in LB medium supplemented with ampicillin to OD 600 = 0.5, and expression was induced with 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). After overnight growth at 18°C, cells were lysed by sonication in 20 mM Tris·HCl (pH 8.5), 500 mM NaCl, and 1 mM EDTA (buffer A). Clarified protein extracts were loaded onto chitin-agarose columns (New England BioLabs) preequilibrated with buffer A and eluted with buffer A supplemented with 50 mM DTT. Anophelin-containing fractions were concentrated and further purified on a HiPrep 16/60 Sephacryl S-100 column (GE Healthcare) preequilibrated with 20 mM Tris·HCl (pH 8.0) and 150 mM NaCl. Protein authenticity was verified by N-terminal sequencing.
A peptide corresponding to the CD Spectroscopy. Far-UV region (190-260 nm) spectra were recorded in a 1.0-mm-path quartz cuvette at 20°C with a Peltier temperature-controlled cell holder-equipped Jasco J-815 spectropolarimeter. Secondary structure content was estimated using DichroWeb (50).
MS Analysis. MALDI TOF/TOF MS analyses were performed using a 4700 Proteomics Analyzer (AB SCIEX) in the linear positive mode. Samples were desalted and concentrated in C18 chromatographic columns (ZipTip; Millipore) according to the manufacturer's protocol and eluted in the presence of appropriate MALDI matrices.
Thrombin Inhibition Assays. The inhibition of the amidolytic activity of titrated (51) bovine α-thrombin (GE Healthcare) was followed spectrophotometrically using Tos-Gly-Pro-Arg-p-nitroanilide (Roche) as chromogenic substrate. The inhibition constants (K i ) of all anophelin variants were determined according to a tight-binding or competitive inhibitor model. Tight-binding inhibitors bind reversibly to and inhibit their target enzyme with a binding energy much greater than substrates (52) . Therefore, an intermediate degree of inhibition is observed when the concentration of inhibitor is comparable with the concentration of enzyme necessary to observe a measurable reaction rate. As a consequence, a significant fraction of the total inhibitor is bound to the enzyme, and the concentration of free inhibitor is not the same as the concentration of total inhibitor, as is assumed for classical inhibitors. Experimentally, substrate depletion in tight-binding inhibition is accounted for by the Morrison equation (53) 
: [1] Tight-binding assays were performed using 0.5 nM bovine α-thrombin, 100 μM substrate, and increasing concentrations (0-80 nM) of inhibitor. The inhibition constant K i was determined by fitting the inhibited steady-state velocity data to the Morrison equation (Eq. 1) using GraphPad Prism 5.0 (GraphPad Software).
By contrast, the binding energy of competitive inhibitors is comparable with the binding energy of substrates, and therefore, the experimental concentration range of the inhibitor is within a few orders of magnitude of the concentration of the substrate and much larger than the concentration of the enzyme. Competitive inhibition assays were performed using 0.5 or 1 nM bovine α-thrombin and increasing concentrations (0-100 μM) of substrate in the presence of inhibitor (0-500 nM). The inhibition constant K i was determined by fitting the observed initial velocity data to the competitive inhibition model (Eq. 2) using GraphPad Prism 5.0 (GraphPad Software), where v is the initial rate of the reaction, v max is the maximum velocity of the reaction, K M is the Michaelis constant for substrate S (7,721 nM), [S] is the concentration of substrate, and K i is the inhibition constant (Eq. 2):
All reactions were carried out at 37°C in 50 mM Tris·HCl (pH 8.0), 100 mM NaCl, and 1 mg/mL BSA in 96-well microtiter plates. Reaction progress was monitored at 405 nm for 1-2 h on a Synergy2 Multimode microplate reader (Biotek).
Dose-response curves (percentage of thrombin inhibition at 120 min as a logarithmic function of the concentration of inhibitor) were used to determine the IC 50 values using GraphPad Prism 5.0 (GraphPad Software).
The inhibition of the amidolytic activity of human γ-thrombin (Haematologic Technologies) was measured as described above for bovine α-thrombin. The final concentrations of substrate, inhibitor, and γ-thrombin were 95 μM, from 0 to 5 μM, and 0.5 nM, respectively. For each inhibitor, at least two independent experiments with duplicate reactions were performed together with control reactions in the absence of enzyme. For all curves, the goodness of fitting parameter R 2 was between 0.964 and 0.998.
DSF Assays. The thermal stability of thrombin·anophelin complexes was assessed by following SYPRO Orange (Invitrogen) fluorescence at 585 nm (excitation = 545 nm) on an iQ5 Real-Time PCR System (BioRad) as a function of temperature (20-95°C in 0.5°C/15-s steps); 20 pmol human α-thrombin (Haematologic Technologies) were mixed with anophelin variants (0-100 pmol) in a 20 μL reaction volume and incubated on ice for 15 min before SYPRO Orange addition to a final concentration of 5× . Duplicate reactions were performed, and controls included no enzyme and no dye. The melting curves were analyzed using CFX Manager (BioRad), and the melting temperature (T m ) was calculated as the inflection point of the curve.
SPR. SPR experiments using CM5 chips were performed at 25°C on a Biacore 3000 (GE Healthcare) with 10 mM Hepes (pH 7.4), 150 mM NaCl, 3 mM EDTA, and 0.005% (vol/vol) P20. Kinetic experiments were performed on flow cells with different amine-coupled human α-thrombin densities and using at least five different analyte concentrations covering three orders of magnitude. D-Phe-LProL-Arg-chloromethyl ketone-inhibited bovine trypsin (Roche) was immobilized to the reference channel as control for nonspecific binding events and bulk refractive index effects. The association and dissociation phases lasted 3 min each, and surface regeneration was achieved with a 5-μL pulse of 10 mM sodium acetate (pH 4.5) and 2 M MgCl 2 . Kinetic parameters (k a and k d ) and equilibrium dissociation constants (K D ) were determined by nonlinear fitting of the sensorgrams to a 1:1 interaction model (Langmuir fitting) using BIAevaluation 4.1.1.
TT Assays. The anticoagulant activity of anophelin mutants was determined by measuring their ability to prolong clotting of human plasma. Human plasma (800 μL) was mixed with 200 μL recombinant anophelin solutions [0-10 μM final concentration in 20 mM Tris·HCl (pH 8.0) and 100 mM NaCl], and TT was measured at BM Análises Clínicas following standard protocols.
Crystallization of Human α-Thrombin·Anophelin Complexes. Human α-thrombin was mixed with a fivefold molar excess of anophelin Aa , incubated on ice for 1 h, and concentrated by ultrafiltration. Crystals grew at 20°C using the sitting-drop method at the High Throughput Crystallization Laboratory of the European Molecular Biology Laboratory (Grenoble, France). Crystals obtained using 100 mM Hepes (pH 7.5) and 1.4 M trisodium citrate belong to space group P3 1 12, whereas crystals grown using 100 mM sodium acetate (pH 4.5) and 3 M NaCl belong to space group H32.
Data Collection and Processing. Crystals cryoprotected in mother liquor supplemented with 10-15% glycerol were flash-cooled in liquid nitrogen, and diffraction data were collected at beam lines ID23-EH1 (54) (space group P3 1 12; wavelength = 0.9792 Å) or ID29 (55) (space group H32; wavelength = 0.9763 Å) of the European Synchrotron Radiation Facility (ESRF; Grenoble, France). Data were processed with XDS (56) and scaled using XSCALE (57) .
Structure Determination and Refinement. The structure of the human α-thrombin·anophelin complex (space group P3 1 12) was solved by molecular replacement with Phaser (58) using the coordinates of free human α-thrombin (Protein Data Bank ID code 3U69) (30, 59 ). The refined model was used as the search model to solve the structure of the other crystal form (space group H32). Alternating cycles of model building with Coot (60) and refinement with PHENIX (61) were performed until model completion. Both complex structures had good stereochemistry, with 100% and 99.0% of the residues in the allowed regions of the Ramachandran plot for the highand low-resolution models, respectively.
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